Ki-Bum Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ki-Bum Lee has a total of 609 co-authors. Here are the top co-authors by number of shared publications:
- Letao Yang
Shanghai Tongji Hospital Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration Ministry of Education Frontier Science Center for Stem Cell Research School of Life Sciences and Technology Tongji University Shanghai 200092 China
36 shared publications - Jeong-Woo Choi
Department of Chemical & Biomolecular Engineering, Sogang University, Seoul, Republic of Korea
17 shared publications - Sy‐Tsong Dean Chueng
Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854 (USA) http://kblee.rutgers.edu
17 shared publications - Perry To‐Tien Yin
Department of Biomedical Engineering, Rutgers, the State University of New Jersey, Piscataway, NJ, 08854, USA
16 shared publications Aniruddh Solanki
Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, 610 Taylor Road, Piscataway, New Jersey 08854, United States
15 shared publications- Hyeon-Yeol Cho
Department of Bio & Fermentation Convergence Technology, Kookmin University, Seoul 02707, Republic of Korea
14 shared publications
Latest Publications
- Open Access
- 8 June 2026
- Published by Elsevier in Cell Biomaterials
- Vol. 2 (10)
Advanced engineering strategies of extracellular vesicles for enhanced central nervous system regeneration and disease modulation
- 8 June 2026
- Published by Elsevier in Cell Biomaterials
- Vol. 2 (10)
Open AccessAdvanced engineering strategies of extracellular vesicles for enhanced central nervous system regeneration and disease modulation
- Open Access
- 19 February 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (8) , 6582-6608
NanoScript-Enabled Nonviral Transient Repression of Phosphatase and Tensin Homolog for Axonal Regeneration and Central Nervous System Injury Repair
Spinal cord injury (SCI) remains a debilitating neurological disorder with limited therapeutic options, as existing treatments primarily address symptoms rather than address the complex interplay of cellular and molecular barriers to regeneration. These barriers collectively hinder functional recovery, including inhibitory glial scarring, chronic neuroinflammation, intrinsic neuronal regenerative deficits, and disruption of the blood-spinal cord barrier (BSCB). To address these limitations, we developed NanoScript-PTEN (NS-PTEN), a nonviral nanoparticle platform that delivers synthetic transcription factors to transiently suppress phosphatase and tensin homolog (PTEN) expression. PTEN negatively regulates the PI3K/AKT/mTOR signaling axis, which is a critical determinant of neuronal survival and axonal growth. By reducing PTEN levels, NS-PTEN derepresses this pro-survival pathway, promoting neuronal regeneration in the injured spinal cord. By integrating a DNA-binding domain targeting the PTEN promoter, a transcriptional repression module, and a nuclear localization signal onto a gold nanoparticle (AuNP) scaffold, NS-PTEN achieves transient control over PTEN repression, reactivating pro-regenerative signaling while minimizing the risks of tumorigenesis associated with permanent gene silencing. In a clinically relevant contusion SCI rat model, NS-PTEN induced a coordinated series of structural and microenvironmental improvements that collectively support spinal cord repair. Histologically, NS-PTEN enhanced axonal continuity and remyelination, as evidenced by denser NF-positive fibers and substantially greater MBP preservation than in both the injury and AuNP groups. Concurrently, NS-PTEN markedly attenuated astroglial and microglial reactivity, reducing GFAP+ border formation and diminishing Iba1+ inflammatory cell accumulation. At the vascular interface, NS-PTEN upregulated CD31 and occludin expression, indicating restored endothelial integrity and the reconstruction of tight junctions, which are critical for BSCB repair. In parallel, the inflammatory milieu shifted toward a regenerative phenotype, characterized by suppressed pro-inflammatory cytokine expression (IL-6, TNF-α, and iNOS) and elevated anti-inflammatory/neurotrophic factors (IL-10 and BDNF). These improvements are consistent with secondary, microenvironment-level benefits arising from acute neuronal PTEN repression rather than direct modification of non-neuronal cell types. Importantly, PTEN expression partially rebounded by DPI-28, aligning with the intended transient activity window of the nanoscript system and supporting its translational safety. Through this combination of precise, nonintegrative gene modulation and broad downstream remodeling, NS-PTEN addresses both intrinsic neuronal limitations and extrinsic inhibitory features of the SCI microenvironment.
- 19 February 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (8) , 6582-6608
Open AccessNanoScript-Enabled Nonviral Transient Repression of Phosphatase and Tensin Homolog for Axonal Regeneration and Central Nervous System Injury Repair
Spinal cord injury (SCI) remains a debilitating neurological disorder with limited therapeutic options, as existing treatments primarily address symptoms rather than address the complex interplay of cellular and molecular barriers to regeneration. These barriers collectively hinder functional recovery, including inhibitory glial scarring, chronic neuroinflammation, intrinsic neuronal regenerative deficits, and disruption of the blood-spinal cord barrier (BSCB). To address these limitations, we developed NanoScript-PTEN (NS-PTEN), a nonviral nanoparticle platform that delivers synthetic transcription factors to transiently suppress phosphatase and tensin homolog (PTEN) expression. PTEN negatively regulates the PI3K/AKT/mTOR signaling axis, which is a critical determinant of neuronal survival and axonal growth. By reducing PTEN levels, NS-PTEN derepresses this pro-survival pathway, promoting neuronal regeneration in the injured spinal cord. By integrating a DNA-binding domain targeting the PTEN promoter, a transcriptional repression module, and a nuclear localization signal onto a gold nanoparticle (AuNP) scaffold, NS-PTEN achieves transient control over PTEN repression, reactivating pro-regenerative signaling while minimizing the risks of tumorigenesis associated with permanent gene silencing. In a clinically relevant contusion SCI rat model, NS-PTEN induced a coordinated series of structural and microenvironmental improvements that collectively support spinal cord repair. Histologically, NS-PTEN enhanced axonal continuity and remyelination, as evidenced by denser NF-positive fibers and substantially greater MBP preservation than in both the injury and AuNP groups. Concurrently, NS-PTEN markedly attenuated astroglial and microglial reactivity, reducing GFAP+ border formation and diminishing Iba1+ inflammatory cell accumulation. At the vascular interface, NS-PTEN upregulated CD31 and occludin expression, indicating restored endothelial integrity and the reconstruction of tight junctions, which are critical for BSCB repair. In parallel, the inflammatory milieu shifted toward a regenerative phenotype, characterized by suppressed pro-inflammatory cytokine expression (IL-6, TNF-α, and iNOS) and elevated anti-inflammatory/neurotrophic factors (IL-10 and BDNF). These improvements are consistent with secondary, microenvironment-level benefits arising from acute neuronal PTEN repression rather than direct modification of non-neuronal cell types. Importantly, PTEN expression partially rebounded by DPI-28, aligning with the intended transient activity window of the nanoscript system and supporting its translational safety. Through this combination of precise, nonintegrative gene modulation and broad downstream remodeling, NS-PTEN addresses both intrinsic neuronal limitations and extrinsic inhibitory features of the SCI microenvironment.
- Open Access
- 8 December 2025
- Published by Wiley in Advanced Science
- Vol. 13 (4) , e16992
Mechanobiological Dynamics‐Inspired Mechanomodulatory Biomaterials
Mechanical cues are fundamental regulators of stem cell fate and play critical roles in various biological processes, including embryogenesis, tissue repair, and regeneration. Successfully reconstructing the complex and dynamic mechanical microenvironments of human tissues necessitates innovative biomaterial designs that surpass conventional approaches. This review provides a comprehensive overview of recent advances in the field of biomaterial‐mediated mechanomodulation of stem cell fate, encompassing both mechanobiological dynamics and dynamic mechanomodulatory biomaterials. It is also discussed how specific material properties, such as stiffness, nanotopography, shear stress, and dynamic stimuli‐responsive behavior, can be used to precisely control stem cell processes, including proliferation, differentiation, migration, and apoptosis. Furthermore, the application of these strategies is examined in both conventional and advanced culture systems, such as organoids and organ‐on‐chip platforms, with a particular focus on tissue‐engineering applications in the neurological, musculoskeletal, and endocrine systems. It is further discussed how material innovations have enabled the development of cutting‐edge techniques for investigating mechanotransduction in stem cells, including force probes, non‐invasive biosensors, materiomics, and machine learning. By integrating knowledge from diverse fields, including medicine, materials science, engineering, biology, and biophysics, this review ultimately aims to inspire the design of smarter biomaterial systems that can accelerate the clinical translation of mechanotherapies and advance the field of regenerative medicine.
- 8 December 2025
- Published by Wiley in Advanced Science
- Vol. 13 (4) , e16992
Open AccessMechanobiological Dynamics‐Inspired Mechanomodulatory Biomaterials
Mechanical cues are fundamental regulators of stem cell fate and play critical roles in various biological processes, including embryogenesis, tissue repair, and regeneration. Successfully reconstructing the complex and dynamic mechanical microenvironments of human tissues necessitates innovative biomaterial designs that surpass conventional approaches. This review provides a comprehensive overview of recent advances in the field of biomaterial‐mediated mechanomodulation of stem cell fate, encompassing both mechanobiological dynamics and dynamic mechanomodulatory biomaterials. It is also discussed how specific material properties, such as stiffness, nanotopography, shear stress, and dynamic stimuli‐responsive behavior, can be used to precisely control stem cell processes, including proliferation, differentiation, migration, and apoptosis. Furthermore, the application of these strategies is examined in both conventional and advanced culture systems, such as organoids and organ‐on‐chip platforms, with a particular focus on tissue‐engineering applications in the neurological, musculoskeletal, and endocrine systems. It is further discussed how material innovations have enabled the development of cutting‐edge techniques for investigating mechanotransduction in stem cells, including force probes, non‐invasive biosensors, materiomics, and machine learning. By integrating knowledge from diverse fields, including medicine, materials science, engineering, biology, and biophysics, this review ultimately aims to inspire the design of smarter biomaterial systems that can accelerate the clinical translation of mechanotherapies and advance the field of regenerative medicine.
- Open Access
- 9 October 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (10) , 682
Multiplexed Optical Nanobiosensing Technologies for Disease Biomarker Detection
Most biomarkers exhibit abnormal expression in more than one disease, making conventional single-biomarker detection strategies prone to false-negative results. Detecting multiple biomarkers associated with a single disease can therefore substantially improve diagnostic accuracy. Accordingly, recent research has focused on precise multiplex detection, leading to the development of sensors employing various readout methods, including electrochemical, fluorescence, Raman, and colorimetric approaches. This review focuses on optical sensing applications, such as fluorescence, Raman spectroscopy, and colorimetry, which offer rapid and straightforward detection and are well suited for point-of-care testing (POCT). These optical sensors exploit nanoscale phenomena derived from the intrinsic properties of nanomaterials, including metal-enhanced fluorescence (MEF), Förster resonance energy transfer (FRET), and surface-enhanced Raman scattering (SERS), which can be tailored through modifications in material type and structure. We summarize the types and properties of commonly used nanomaterials, including plasmonic and carbon-based nanoparticles, and provide a comprehensive overview of recent advances in multiplex biomarker detection. Furthermore, we address the potential of these nanosensors for clinical translation and POCT applications, highlighting their relevance for next-generation disease diagnostic platforms.
- 9 October 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (10) , 682
Open AccessMultiplexed Optical Nanobiosensing Technologies for Disease Biomarker Detection
Most biomarkers exhibit abnormal expression in more than one disease, making conventional single-biomarker detection strategies prone to false-negative results. Detecting multiple biomarkers associated with a single disease can therefore substantially improve diagnostic accuracy. Accordingly, recent research has focused on precise multiplex detection, leading to the development of sensors employing various readout methods, including electrochemical, fluorescence, Raman, and colorimetric approaches. This review focuses on optical sensing applications, such as fluorescence, Raman spectroscopy, and colorimetry, which offer rapid and straightforward detection and are well suited for point-of-care testing (POCT). These optical sensors exploit nanoscale phenomena derived from the intrinsic properties of nanomaterials, including metal-enhanced fluorescence (MEF), Förster resonance energy transfer (FRET), and surface-enhanced Raman scattering (SERS), which can be tailored through modifications in material type and structure. We summarize the types and properties of commonly used nanomaterials, including plasmonic and carbon-based nanoparticles, and provide a comprehensive overview of recent advances in multiplex biomarker detection. Furthermore, we address the potential of these nanosensors for clinical translation and POCT applications, highlighting their relevance for next-generation disease diagnostic platforms.
- Open Access
- 8 September 2025
- Published by Wiley in Advanced Science
- Vol. 12 (44) , e04147
Advanced Biomaterial Delivery of Hypoxia‐Conditioned Extracellular Vesicles (EVs) as a Therapeutic Platform for Traumatic Brain Injury
Traumatic Brain Injury (TBI) is a common and debilitating injury, causing long‐lasting neurological deficits. Current therapeies for recovery remain inadequate, undersing the urgent need for innovative interventions. In this study, a novel therapeutic approach is introduced that delivers extracellular vesicles (EVs) derived from human‐induced pluripotent stem cell‐derived neural progenitor cells (hiPSC‐NPCs) with a gelatin‐based injectable bioorthogonal hydrogel (BIOGEL). The hiPSC‐NPCs are conditioned with deferoxamine (DFO) to simulate hypoxia, resulting in EVs enriched with neurotrophic and angiogenic factors critical for neural repair. The biomimetic mechanical properties of BIOGEL, similar to those of native brain tissue, contribute to sustained EV delivery and promote neural regeneration. BIOGEL with hypoxia‐conditioned EVs showed significant tissue regeneration in vivo using a rat model of TBI. Our nanomaterial platform reduced cortical lesions, improved neurological and motor recovery, enhanced hippocampal neurogenesis and myelination, and reduced neuroinflammation, demonstrating strong therapeutic potential for neural repair. In summary, this study demonstrated proof‐of‐concept for a multifaceted therapeutic platform that simultaneously targets key pathological features of TBI, providing a scalable and clinically translatable approach to effective neural tissue regeneration. The synergistic combination of hypoxia‐conditioned EVs and biomaterial delivery offers a promising strategy for advancing regenerative medicine techniques for neural repair.
- 8 September 2025
- Published by Wiley in Advanced Science
- Vol. 12 (44) , e04147
Open AccessAdvanced Biomaterial Delivery of Hypoxia‐Conditioned Extracellular Vesicles (EVs) as a Therapeutic Platform for Traumatic Brain Injury
Traumatic Brain Injury (TBI) is a common and debilitating injury, causing long‐lasting neurological deficits. Current therapeies for recovery remain inadequate, undersing the urgent need for innovative interventions. In this study, a novel therapeutic approach is introduced that delivers extracellular vesicles (EVs) derived from human‐induced pluripotent stem cell‐derived neural progenitor cells (hiPSC‐NPCs) with a gelatin‐based injectable bioorthogonal hydrogel (BIOGEL). The hiPSC‐NPCs are conditioned with deferoxamine (DFO) to simulate hypoxia, resulting in EVs enriched with neurotrophic and angiogenic factors critical for neural repair. The biomimetic mechanical properties of BIOGEL, similar to those of native brain tissue, contribute to sustained EV delivery and promote neural regeneration. BIOGEL with hypoxia‐conditioned EVs showed significant tissue regeneration in vivo using a rat model of TBI. Our nanomaterial platform reduced cortical lesions, improved neurological and motor recovery, enhanced hippocampal neurogenesis and myelination, and reduced neuroinflammation, demonstrating strong therapeutic potential for neural repair. In summary, this study demonstrated proof‐of‐concept for a multifaceted therapeutic platform that simultaneously targets key pathological features of TBI, providing a scalable and clinically translatable approach to effective neural tissue regeneration. The synergistic combination of hypoxia‐conditioned EVs and biomaterial delivery offers a promising strategy for advancing regenerative medicine techniques for neural repair.
- Top Cited Papers
- 4 September 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (36) , 31933-31968
33 Unresolved Questions in Nanoscience and Nanotechnology
Significant advances in science and engineering often emerge at the intersections of disciplines. Nanoscience and nanotechnology are inherently interdisciplinary, uniting researchers from chemistry, physics, biology, medicine, materials science, and engineering. This convergence has fostered novel ways of thinking and enabled the development of materials, tools, and technologies that have transformed both basic and applied research, as well as how we address critical societal challenges. In this Nano Focus, we pose and explore 33 questions whose answers could profoundly impact fields such as energy, electronics, the environment, optics, and medicine. These questions highlight the need for deeper foundational understanding, improved tools and techniques, and innovative applications─each with significant societal relevance. Together, they represent a global call-to-action for the scientific community.
- 4 September 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (36) , 31933-31968
Top Cited Papers33 Unresolved Questions in Nanoscience and Nanotechnology
Significant advances in science and engineering often emerge at the intersections of disciplines. Nanoscience and nanotechnology are inherently interdisciplinary, uniting researchers from chemistry, physics, biology, medicine, materials science, and engineering. This convergence has fostered novel ways of thinking and enabled the development of materials, tools, and technologies that have transformed both basic and applied research, as well as how we address critical societal challenges. In this Nano Focus, we pose and explore 33 questions whose answers could profoundly impact fields such as energy, electronics, the environment, optics, and medicine. These questions highlight the need for deeper foundational understanding, improved tools and techniques, and innovative applications─each with significant societal relevance. Together, they represent a global call-to-action for the scientific community.
- Open Access
- 28 July 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (35) , 31438-31456
Advanced Cancer Liquid Biopsy Platform for miRNA Detection in Extracellular Vesicles Using CRISPR/Cas13a and Gold Nanoarrays
Liquid biopsy is a transformative, noninvasive tool for cancer diagnosis and monitoring, with the potential to revolutionize personalized medicine. In this study, we introduce an advanced liquid biopsy platform for highly sensitive and selective detection of extracellular vesicle (EV) microRNAs (miRNA-21 and miRNA-23a) as biomarkers for colorectal cancer. The platform combines two innovations: (1) gold nanoarrays with epithelial cell adhesion molecule (EpCAM)-specific aptamers to selectively isolate tumor-derived EVs from plasma and (2) CRISPR/Cas13a-encapsulated liposomes that fuse with EVs to form nanoscale reactors. Upon fusion, the CRISPR/Cas13a complex is activated by target miRNA, triggering trans-cleavage of RNA reporters and generating an amplified fluorescence signal for enhanced detection sensitivity. The assay achieves a linear detection range of 10 to 106 EVs/μL and a detection limit of 2.5 × 101 EVs/μL on the gold nanoarray. Its performance relies on three strategies: (i) EpCAM-mediated tumor EV enrichment, (ii) CRISPR/Cas13a-based collateral activity for ultrasensitive miRNA detection, and (iii) fluorescence signal enhancement via localized nanoreactors. Validation with a 2D SW480 cell model, a 3D vascularized tumor spheroid (VTS) model, and clinical plasma samples confirms diagnostic accuracy, with miRNA quantification comparable to RT-qPCR but without the need for labor-intensive RNA extraction and amplification. By integrating nanotechnology with CRISPR-based diagnostics, this platform bridges research and clinical translation, improving diagnostic precision and streamlining workflows. Future development will focus on multiplexed biomarker detection and single-EV analysis to reveal insights into EV heterogeneity and function in cancer. This technology supports the application in precision oncology, offering a tool for early detection, treatment monitoring, and therapeutic decision-making.
- 28 July 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (35) , 31438-31456
Open AccessAdvanced Cancer Liquid Biopsy Platform for miRNA Detection in Extracellular Vesicles Using CRISPR/Cas13a and Gold Nanoarrays
Liquid biopsy is a transformative, noninvasive tool for cancer diagnosis and monitoring, with the potential to revolutionize personalized medicine. In this study, we introduce an advanced liquid biopsy platform for highly sensitive and selective detection of extracellular vesicle (EV) microRNAs (miRNA-21 and miRNA-23a) as biomarkers for colorectal cancer. The platform combines two innovations: (1) gold nanoarrays with epithelial cell adhesion molecule (EpCAM)-specific aptamers to selectively isolate tumor-derived EVs from plasma and (2) CRISPR/Cas13a-encapsulated liposomes that fuse with EVs to form nanoscale reactors. Upon fusion, the CRISPR/Cas13a complex is activated by target miRNA, triggering trans-cleavage of RNA reporters and generating an amplified fluorescence signal for enhanced detection sensitivity. The assay achieves a linear detection range of 10 to 106 EVs/μL and a detection limit of 2.5 × 101 EVs/μL on the gold nanoarray. Its performance relies on three strategies: (i) EpCAM-mediated tumor EV enrichment, (ii) CRISPR/Cas13a-based collateral activity for ultrasensitive miRNA detection, and (iii) fluorescence signal enhancement via localized nanoreactors. Validation with a 2D SW480 cell model, a 3D vascularized tumor spheroid (VTS) model, and clinical plasma samples confirms diagnostic accuracy, with miRNA quantification comparable to RT-qPCR but without the need for labor-intensive RNA extraction and amplification. By integrating nanotechnology with CRISPR-based diagnostics, this platform bridges research and clinical translation, improving diagnostic precision and streamlining workflows. Future development will focus on multiplexed biomarker detection and single-EV analysis to reveal insights into EV heterogeneity and function in cancer. This technology supports the application in precision oncology, offering a tool for early detection, treatment monitoring, and therapeutic decision-making.
- Open Access
- 11 June 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (45)
Engineering Topographical Cues to Enhance Neural Regeneration in Spinal Cord Injury: Overcoming Challenges and Advancing Therapies
Spinal cord injury (SCI) poses significant challenges for regeneration due to a series of secondary injury mechanisms, including ischemia, oxidative stress, and neuroinflammation. These pathological processes lead to neuronal apoptosis and create a microenvironment that hinders neural regeneration. Recent advancements in tissue engineering have introduced biomaterials that feature precisely engineered micro‐ and nanoscale topographical cues, representing a novel class of therapeutic interventions. These biomimetic scaffolds are designed to modulate the mechanotransduction pathways of neural stem cells (NSCs), thereby enhancing neurogenesis and guiding neuronal differentiation. They also influence essential cellular processes such as adhesion, cytoskeletal alignment, morphological polarization, and gene regulation. This review systematically evaluates current strategies for optimizing topographical designs, emphasizing their role in promoting neurite outgrowth, axonal guidance, and synaptic reformation. The mechanisms are elucidated by which scaffold topographies regulate NSC fate decisions through mechanobiological signaling and interactions with the extracellular matrix. Additionally, critical barriers are analyzed for clinical translation, including the precision fabrication of tunable architectures, the scalability of novel materials, and strategies to mitigate glial scar formation. By synthesizing interdisciplinary insights from biomaterial science, neurobiology, and translational medicine, this work aims to provide a roadmap for developing next‐generation topographical scaffolds that address the pressing clinical need for effective SCI repair.
- 11 June 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (45)
Open AccessEngineering Topographical Cues to Enhance Neural Regeneration in Spinal Cord Injury: Overcoming Challenges and Advancing Therapies
Spinal cord injury (SCI) poses significant challenges for regeneration due to a series of secondary injury mechanisms, including ischemia, oxidative stress, and neuroinflammation. These pathological processes lead to neuronal apoptosis and create a microenvironment that hinders neural regeneration. Recent advancements in tissue engineering have introduced biomaterials that feature precisely engineered micro‐ and nanoscale topographical cues, representing a novel class of therapeutic interventions. These biomimetic scaffolds are designed to modulate the mechanotransduction pathways of neural stem cells (NSCs), thereby enhancing neurogenesis and guiding neuronal differentiation. They also influence essential cellular processes such as adhesion, cytoskeletal alignment, morphological polarization, and gene regulation. This review systematically evaluates current strategies for optimizing topographical designs, emphasizing their role in promoting neurite outgrowth, axonal guidance, and synaptic reformation. The mechanisms are elucidated by which scaffold topographies regulate NSC fate decisions through mechanobiological signaling and interactions with the extracellular matrix. Additionally, critical barriers are analyzed for clinical translation, including the precision fabrication of tunable architectures, the scalability of novel materials, and strategies to mitigate glial scar formation. By synthesizing interdisciplinary insights from biomaterial science, neurobiology, and translational medicine, this work aims to provide a roadmap for developing next‐generation topographical scaffolds that address the pressing clinical need for effective SCI repair.
- Open Access
- 10 June 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (26) , 10402-10411
Real-Time Intracellular Monitoring of miRNA Dynamics during Induced Pluripotent Stem Cell Neuronal Differentiation via Plasmon-Enhanced Nanobiosensing
Induced pluripotent stem cells (iPSCs) offer immense potential for treating central nervous system (CNS) disorders and injuries. However, the lack of highly sensitive, selective, and noninvasive biosensors for real-time monitoring of iPSC neuronal differentiation remains a critical barrier. In this work, we introduce a gold nanorod-based metal-enhanced molecular beacon (MEMB) nanobiosensor for the noninvasive, real-time detection of intracellular miRNA-124, a key biomarker for neuronal differentiation in human iPSC-derived neural stem cells. Designed through finite-difference time-domain (FDTD) simulations and experimentally validated for optimized localized surface plasmon resonance (LSPR) properties, MEMB nanobiosensors achieved picomolar-level sensitivity and single-mismatch selectivity toward miRNA-124 detection, along with great biocompatibility demonstrated by live-cell assays. Collectively, the MEMB platform provides a robust analytical tool for in-depth investigations of molecular and genetic regulatory networks during iPSC neuronal differentiation in a nondestructive manner, paving the way toward safer, more efficient, and better-characterized iPSC-derived cell therapies for CNS diseases and injuries.
- 10 June 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (26) , 10402-10411
Open AccessReal-Time Intracellular Monitoring of miRNA Dynamics during Induced Pluripotent Stem Cell Neuronal Differentiation via Plasmon-Enhanced Nanobiosensing
Induced pluripotent stem cells (iPSCs) offer immense potential for treating central nervous system (CNS) disorders and injuries. However, the lack of highly sensitive, selective, and noninvasive biosensors for real-time monitoring of iPSC neuronal differentiation remains a critical barrier. In this work, we introduce a gold nanorod-based metal-enhanced molecular beacon (MEMB) nanobiosensor for the noninvasive, real-time detection of intracellular miRNA-124, a key biomarker for neuronal differentiation in human iPSC-derived neural stem cells. Designed through finite-difference time-domain (FDTD) simulations and experimentally validated for optimized localized surface plasmon resonance (LSPR) properties, MEMB nanobiosensors achieved picomolar-level sensitivity and single-mismatch selectivity toward miRNA-124 detection, along with great biocompatibility demonstrated by live-cell assays. Collectively, the MEMB platform provides a robust analytical tool for in-depth investigations of molecular and genetic regulatory networks during iPSC neuronal differentiation in a nondestructive manner, paving the way toward safer, more efficient, and better-characterized iPSC-derived cell therapies for CNS diseases and injuries.
- Open Access
Multifunctional Bioactive Dual‐Layered Nanofibrous Matrix for Effective Breast Cancer Therapy and Enhanced Wound Healing
Surgical resection is the primary treatment for triple‐negative breast cancer (TNBC). Post‐operative complications, including tumor recurrence and bacterial infections, hinder complete remission and long‐term recovery. To address these challenges, a multifunctional bioactive dual‐layered nanofibrous matrix (MBDL‐NanoMat) featuring adaptive shape control, excellent wound adherence, tunable drug release profiles, and superior biocompatibility for post‐surgical applications is developed. The MBDL‐NanoMat comprises a hydrophilic (HyPhil) layer and a hydrophobic (HyPhob) layer, offering distinct functionalities. The HyPhil layer, electrospun with gelatin and copper peroxide nanoparticles (Cu NPs), rapidly releases Cu NPs to induce anticancer effects through chemodynamic therapy (CDT), ferroptosis, and cuproptosis along with antibacterial action. Near‐infrared laser irradiation enhances therapeutic efficacy through photothermal therapy (PTT). The HyPhob layer ensures prolonged therapeutic effects by releasing therapeutic molecules, such as rapamycin, enabling sustained chemotherapy (CT) and antibacterial activity. This synergistic therapeutic system integrates multiple mechanisms—CT, CDT, PTT, ferroptosis, and cuproptosis—suppressing tumor recurrence and accelerating wound healing. Preclinical results demonstrated enhanced angiogenesis, collagen deposition, and dermal regeneration without systemic safety. In short, the MBDL‐NanoMat platform offers a unique advantage in post‐surgical TNBC care by simultaneously targeting tumor recurrence and facilitating wound healing. Further investigation of this platform can significantly improve oncological and regenerative medicine strategies.
Open AccessMultifunctional Bioactive Dual‐Layered Nanofibrous Matrix for Effective Breast Cancer Therapy and Enhanced Wound Healing
Surgical resection is the primary treatment for triple‐negative breast cancer (TNBC). Post‐operative complications, including tumor recurrence and bacterial infections, hinder complete remission and long‐term recovery. To address these challenges, a multifunctional bioactive dual‐layered nanofibrous matrix (MBDL‐NanoMat) featuring adaptive shape control, excellent wound adherence, tunable drug release profiles, and superior biocompatibility for post‐surgical applications is developed. The MBDL‐NanoMat comprises a hydrophilic (HyPhil) layer and a hydrophobic (HyPhob) layer, offering distinct functionalities. The HyPhil layer, electrospun with gelatin and copper peroxide nanoparticles (Cu NPs), rapidly releases Cu NPs to induce anticancer effects through chemodynamic therapy (CDT), ferroptosis, and cuproptosis along with antibacterial action. Near‐infrared laser irradiation enhances therapeutic efficacy through photothermal therapy (PTT). The HyPhob layer ensures prolonged therapeutic effects by releasing therapeutic molecules, such as rapamycin, enabling sustained chemotherapy (CT) and antibacterial activity. This synergistic therapeutic system integrates multiple mechanisms—CT, CDT, PTT, ferroptosis, and cuproptosis—suppressing tumor recurrence and accelerating wound healing. Preclinical results demonstrated enhanced angiogenesis, collagen deposition, and dermal regeneration without systemic safety. In short, the MBDL‐NanoMat platform offers a unique advantage in post‐surgical TNBC care by simultaneously targeting tumor recurrence and facilitating wound healing. Further investigation of this platform can significantly improve oncological and regenerative medicine strategies.